Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma

Tissue factor (TF) is a transmembrane glycoprotein to initiate blood coagulation and frequently overexpressed in a variety of tumors. Our previous study has showed that the expression of TF is upregulated and correlated with prognosis in hepatocellular carcinoma (HCC). However, the role and molecula...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Huang, Shan-Zhou, Wei, Meng-Ning, Huang, Jia-Rong, Zhang, Zi-Jian, Zhang, Wen-Ji, Jiang, Qi-Wei, Yang, Yang, Wang, Huan-Yu, Jin, Hui-Lin, Wang, Kun, Xing, Zi-Hao, Yuan, Meng-Ling, Li, Yao, He, Xiao-Shun, Shi, Zhi, Zhou, Qi
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6428933/
https://ncbi.nlm.nih.gov/pubmed/30931258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00150
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados